April 2, 2018

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

AMENDMENTS AND UPDATES
GYNECOLOGIC
GOG-0239:Amendment 11; version date: March 6, 2018 (posted on NRG Oncology).

OTHER PROTOCOL NOTICES
1. BREAST
NRG-BR003: Memo and Revised Required Studies Checklist Tool (posted to CTSU).

RTOG 1119: Study Memorandum dated April 2, 2018, posted on the protocol-specific page of the CTSU website, corrects the NRG Oncology Biospecimen Bank email listed in Appendix III.

2. COLORECTAL
NRG-GI004: E-mail Blast (posted to CTSU).

3. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next webinar training is scheduled for April 11, 2018.

DRUG SAFETY UPDATES

Safety updates have been issued for the following NRG Oncology studies:

- Ipilimumab: NRG-GY003
- Nivolumab:  NRG-BN002, NRG-GY002, NRG-GY003
- Trametinib: GOG-0281
  • For GOG-0281 safety reports, please see CTSU for details.
  • For NRG-GY002 and NRG-GY003 safety reports, please see the protocol page on NRG Oncology for details.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.


JOURNAL ARTICLES

Boxerman JL, Zhang Z, Safriel Y, Rogg JM, Wolf RL, Mohan S, Marques H, Sorensen AG, Gilbert MR, Barboriak DP. Prognostic Value of Contrast Enhancement and FLAIR for Survival in Newly Diagnosed Glioblastoma Treated With and Without Bevacizumab: Results from ACRIN 6686. Neuro Oncol. 2018 Mar 26. doi: 10.1093/neuonc/noy049. [Epub ahead of print] PubMed PMID: 29590461. Read more

Konski A, Bhargavan M, Owen J, Komaki R, Langer CJ, Gore E, Paulus P, Choy H, Bruner DW, Curran WJ. An economic analysis of Radiation Therapy Oncology Group 94-10: cost-efficacy of concurrent vs. sequential chemoradiotherapy. J Radiat Oncol. 2018 Mar 10. [Epub ahead of print] Read more

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American Association for Cancer Research (AACR); Apr 14-18, 2018; Chicago, IL

American Association of Neurological Surgeons (AANS); Apr 28 - May 2, 2018 New Orleans, LA

American Association for Thoracic Surgery (AATS); Apr 28 - May 1, 2018; San Diego, CA

American Head & Neck Society (AHNS); Apr 18-19, 2018; National Harbor, MD

American Radium Society (ARS); May 5-8, 2018; Orlando, FL

American Society of Breast Surgeons (ASBS); May 2-6, 2018; Orlando, FL

European Society for Radiotherapy and Oncology (ESTRO);Apr 20-24, 2018; Barcelona, Spain


Upcoming Abstract Submission Deadlines

American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Diego, CA; Late-breaking Aug 1, 2018

European Society for Medical Oncology (ESMO); Oct 19-23, 2018;Munich, Germany; due to publications committee Apr 25, 2018; meeting abstracts submission deadline May 9, 2018; Late-breaking Sep 17, 2018

International Society for Quality of Life Research (ISOQOL); Oct 24-27, 2018; Dublin, Ireland; due to publications committee Apr 2, 2018; meeting abstracts submission deadline Apr 16, 2018

Multinational Association of Supportive Care in Cancer (MASCC); Jun 28-30, 2018; Vienna, Austria; Late-breaking due Apr 22, 2018


NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Unsubscribe